CLSA downgraded XPeng (NYSE: XPEV) to an Outperform rating (From Buy) and raised their 12-month target price to $13.10 (From ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE